Otros idiomas Biogen Inc. Xetra

Acciones

IDP

US09062X1037

Tiempo real estimado Tradegate Otros sitios de cotización 17:49:18 22/05/2024			Varia. Cinco días.	Varia. 1 de enero.
207,4 ^EUR	-0,79 %		-3,77 %	-11,97 %

17:00	BIOGEN INC. : Wedbush da una recomendación neutral	ZM
14:18	Biogen adquirirá Human Immunology Biosciences por hasta 1.800 millones de dólares	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

MÄRKTE USA/Börsen treten auf der Stelle - Fed-Protokoll und Nvidia im Fokus	15:45
Biogen : accord pour l'acquisition de HI-Bio	15:33
Biogen rachète HI-Bio pour un montant pouvant atteindre 1,8 milliard de dollars	14:55
Biogen to Acquire Human Immunology Biosciences for up to $1.8 Billion	14:18
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal	13:37
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences	13:30
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	16/05
Sector Update: Health Care Stocks Ease Thursday Afternoon	16/05
US Equity Indexes Trade Mixed as Investors Weigh Macro Data; Dow Touches Record High	16/05
Sector Update: Health Care	16/05
Dow Touches 40,000 Mark for First Time as Macroeconomic Data Signals Economic Weakness	16/05
Ionis Pharmaceuticals Says Potential Angelman Syndrome Therapy Improves Symptoms in Phase 1/2a Study	16/05
Stocks in motion: Walmart, Chubb, Deere...	16/05
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status	16/05
Sector Update: Health Care Stocks Steady Premarket Thursday	16/05
Biogen, Ionis to Cease BIIB105 ALS Investigational Drug Development Following Phase 1/2 Trial Results	16/05
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16/05
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16/05
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16/05
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon	15/05

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Biogen Inc. Xetra

Acciones

IDP

US09062X1037

Otros idiomas

Filtros